Ascension Orthopedics, a medical device company focusing on the lower and upper extremities, will represent approximately 45 percent of Integra’s orthopedics revenue. The company will make a significant contribution to Integra’s upper extremity and shoulder portfolio.
The acquisition also means Ascensions’ differentiated pyrolytic carbon technology will be brought to Integra. The company’s PyroCarbon is a specific form of carbon with manufactured crystalline structures for enhanced strength and wear characteristics.
Over the last 12 months ending in June, Ascension generated approximately $19 million.
Related Articles on Orthopedic Device Companies:
42 Orthopedic and Spine Devices Receive FDA 510(k) Clearance in August
MedShape Solutions Receives Small Business Innovation Research Grant
Zimmer Supports Orthopedic Mission Trip to Nigeria
